financetom
financetom
/
Terms and Conditions
Terms and Conditions for Website Use

1. Acceptance of Terms

By using this website, you agree to be bound by these terms and conditions, which we may update from time to time. If you do not agree to these terms and conditions, please do not use this website.

2. Use of Website Content

The content of this website, including but not limited to text, images, and videos, is protected by copyright and other intellectual property laws. You may view, download, or print the content for your personal use, but you may not republish, sell, or modify any of the content without the express written consent of the website operator.

3. Disclaimer of Liability

This website provides information and services free of charge, and we do not guarantee the accuracy, completeness, or timeliness of the content. We disclaim all liability for any errors or omissions in the content of this website. Use of this website is at your own risk.

4. Links to Other Websites

This website may contain links to other websites. We do not control or endorse the content of any linked websites, and we are not responsible for any transactions you may have with such websites.

5. No Spamming

You may not use this website to send spam or engage in any other unsolicited advertising or marketing activities. We reserve the right to terminate your access to this website if we determine that you are using it for spamming or other unauthorized purposes.

6. No Illegal Activities

You may not use this website for any illegal activities, including but not limited to accessing or disclosing personal information about others without their consent. Any violation of these terms and conditions may result in legal action against you.

Related Articles >
Regeneron Pharmaceuticals' Ebola Antibody Recommended by WHO for Investigational Use in Bundibugyo Ebolavirus
Regeneron Pharmaceuticals' Ebola Antibody Recommended by WHO for Investigational Use in Bundibugyo Ebolavirus
May 28, 2026
05:30 PM EDT, 05/28/2026 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said late Thursday that maftivimab, the most potent neutralizing antibody included in Inmazeb, has been recommended by the World Health Organization's Therapeutics Advisory Group to be prioritized for evaluation in clinical trials of investigational treatments for Bundibugyo ebolavirus. Maftivimab has demonstrated broad activity in vitro against multiple Ebola...
Emergent BioSolutions Wins $64.5 Million US Government Contract Modification for BAT
Emergent BioSolutions Wins $64.5 Million US Government Contract Modification for BAT
May 28, 2026
05:31 PM EDT, 05/28/2026 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Thursday it was awarded a contract modification valued at about $64.5 million from the US Department of Health and Human Services' Administration for Strategic Preparedness and Response for BAT, its botulism antitoxin treatment. The modification was made under an existing 10-year contract with ASPR under which Emergent...
Alexander's Completes $235.5 Million Sale of Rego Park I to Northwell Health
Alexander's Completes $235.5 Million Sale of Rego Park I to Northwell Health
May 28, 2026
05:33 PM EDT, 05/28/2026 (MT Newswires) -- Alexander's (ALX) said Thursday it completed the sale of its Rego Park I property in Queens, New York, to Northwell Health for $235.5 million. The real estate investment trust received $224 million in proceeds at closing. Net proceeds totaled $203 million after $21 million in previously paid costs. The company expects to recognize...
Venture Global Insider Sold Shares Worth $6,430,640, According to a Recent SEC Filing
Venture Global Insider Sold Shares Worth $6,430,640, According to a Recent SEC Filing
May 28, 2026
05:36 PM EDT, 05/28/2026 (MT Newswires) -- Fory Musser, Senior Vice President, Development, on May 26, 2026, sold 500,000 shares in Venture Global ( VG ) for $6,430,640. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007855/000205037226000011/xslF345X05/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved